You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

verteporfin

Showing 1 - 25 of 126
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Trial in Rochester

Recruiting
  • Advanced Pancreatic Carcinoma
  • +9 more
  • Endoscopic Ultrasound
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 13, 2022

Glioblastoma, Recurrent Glioblastoma Trial in Atlanta (Verteporfin)

Recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Verteporfin
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 17, 2022

Recurrent Prostate Cancer Trial in Philadelphia, Toronto, London (Verteporfin, SpectraCure P18 System)

Recruiting
  • Recurrent Prostate Cancer
  • Verteporfin
  • SpectraCure P18 System
  • New York, New York
  • +3 more
Nov 15, 2022

Choroidal Blood Flow in Acute and Chronic Central Serous

Recruiting
  • Central Serous Chorioretinopathy
  • Verteporfin
  • Stavanger, Norway
    Stavanger University Hospital, Department of Ophthalmology
Oct 18, 2022

Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

Not yet recruiting
  • Exudative Age Related Macular Degeneration
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences
Nov 28, 2022

Central Serous Chorioretinopathy, Therapy, Photodynamic Trial in Beijing (50% dose of photodynamic therapy, 70% dose of

Recruiting
  • Central Serous Chorioretinopathy
  • Therapy, Photodynamic
  • 50% dose of photodynamic therapy
  • 70% dose of photodynamic therapy
  • Beijing, Beijing, China
    Peking University People's Hospital
May 21, 2022

Age-Related Maculopathy, Choroidal Neovascularization Trial in Tulsa (Ranibizumab, Verteporfin)

Completed
Has Results
  • Age-Related Maculopathy
  • Choroidal Neovascularization
  • Tulsa, Oklahoma
    Eagle Mountain Vision
Nov 4, 2020

Port Wine Stains Trial in Irvine (Combined Photodynamic & Pulsed Dye Laser Treatment)

Completed
Has Results
  • Port Wine Stains
  • Combined Photodynamic & Pulsed Dye Laser Treatment
  • Irvine, California
    Beckman Laser Medical Clinic,University
Oct 19, 2022

Polypoidal Choroidal Vasculopathy Trial in Shanghai, Hangzhou, Wenzhou (conbercept, Initial PDT, Delayed PDT)

Completed
  • Polypoidal Choroidal Vasculopathy
  • Shanghai, Shanghai, China
  • +2 more
Jul 17, 2019

Photodynamic Therapy for PDA in NV AMD

Completed
  • Neovascular Age-related Macular Degeneration
  • Macular Degeneration
  • No Intervention
  • Durham, North Carolina
    Duke Eye Center
Nov 8, 2021

Choroidal Neovascularization, Choroid Disease Trial in Palermo (Aflibercept Injection)

Completed
  • Choroidal Neovascularization
  • Choroid Disease
  • Aflibercept Injection
  • Palermo, Italy
    Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
Aug 30, 2019

Polypoidal Choroidal Vasculopathy Trial in Singapore (Aflibercept + reduced fluence photodynamic therapy (RF-PDT), Aflibercept +

Recruiting
  • Polypoidal Choroidal Vasculopathy
  • Aflibercept + reduced fluence photodynamic therapy (RF-PDT)
  • Aflibercept + sham reduced fluence photodynamic therapy (RF-PDT)
  • Singapore, Singapore
  • +2 more
Nov 14, 2022

Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM) Trial in Worldwide (Ranibizumab

Completed
Has Results
  • Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)
  • Ranibizumab 0.5mg
  • +2 more
  • Beijing, Beijing, China
  • +46 more
Mar 31, 2019

Age-related Macular Degeneration, Polypoidal Choroidal Vasculopathy Trial in Worldwide (Ranibizumab, Verteporfin PDT, Sham PDT)

Completed
Has Results
  • Age-related Macular Degeneration
  • Polypoidal Choroidal Vasculopathy
  • Hong Kong, Hong Kong
  • +41 more
Mar 5, 2019

Acute Central Serous Chorioretinopathy Trial in Guangzhou (577-MPL, HD-PDT)

Completed
  • Acute Central Serous Chorioretinopathy
  • 577-MPL
  • HD-PDT
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Apr 4, 2022

Age-Related Macular Degeneration Trial in Hong Kong (Brolucizumab, Aflibercept)

Recruiting
  • Age-Related Macular Degeneration
  • Hong Kong, Hong Kong
    Grantham Hospital
Jan 25, 2023

Pleural Effusion, Malignant Trial in Lausanne (Cisplatin, liposomal, Verteporfin, Device for Intrapleural Visudyne-mediated

Terminated
  • Pleural Effusion, Malignant
  • Cisplatin, liposomal
  • +2 more
  • Lausanne, Vaud (VD), Switzerland
    Oncology Department, Centre Hospitalier Universitaire Vaudois (C
Mar 18, 2019

Metastatic Breast Cancer Trial in Boston (Verteporfin, Continuous Low-Irradiance Photodynamic Therapy (CLIPT))

Unknown status
  • Metastatic Breast Cancer
  • Verteporfin
  • Continuous Low-Irradiance Photodynamic Therapy (CLIPT)
  • Boston, Massachusetts
  • +1 more
Jul 18, 2018

Central Serous Chorioretinopathy Trial in Hong Kong

Recruiting
  • Central Serous Chorioretinopathy
    • Hong Kong, Hong Kong
    • +2 more
    Apr 19, 2022

    Polypoidal Choroidal Vasculopathy Trial in Portugal, Spain (Intravitreal Aflibercept)

    Completed
    • Polypoidal Choroidal Vasculopathy
    • Intravitreal Aflibercept
    • Braga, Portugal
    • +12 more
    Jan 8, 2020

    Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)

    Recruiting
    • Exudative Macular Degeneration
    • Wet Age-related Macular Degeneration
    • Doxycycline Hyclate
    • Placebo
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics Department of Ophthalmolo
    Apr 5, 2022

    Retinoblastoma Trial in Guangzhou (photodynamic therapy)

    Completed
    • Retinoblastoma
    • photodynamic therapy
    • Guangzhou, Guangdong, China
      Kunbei Lai
    Jun 10, 2020

    Radiation Retinopathy Trial in United States (0.5 mg ranibizumab, Targeted Retinal Photocoagulation (TRP))

    Completed
    Has Results
    • Radiation Retinopathy
    • 0.5 mg ranibizumab
    • Targeted Retinal Photocoagulation (TRP)
    • Dallas, Texas
    • +3 more
    Mar 24, 2021

    Breast Tumors Trial in London (Verteporfin)

    Completed
    • Breast Neoplasms
    • Verteporfin
    • London, United Kingdom
      Royal Free Hospital
    Apr 4, 2018

    Polypoidal Choroidal Vasculopathy Trial in Guangzhou (verteporfin, verteporfin and ranibizumab)

    Completed
    • Polypoidal Choroidal Vasculopathy
    • verteporfin
    • verteporfin and ranibizumab
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Mar 2, 2018